Rebamipide a gastroprotective drug, is clinically used for the treatment of gastric ulcers and gastritis, but its actions on gastric cancer are not clearly understood. Phospholipase D (PLD) is ...

Discover comprehensive details about Rebamipide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

What works for the stomach may also work for the eyes: a 2% rebamipide suspension was objectively and subjectively superior to a 0.1% sodium hyaluronate solution for treatment of dry eye, according to ...

If you are troubled by abdominal bloating due to excess gas, gas bloat syndrome is what you might have. Seemingly harmless, it can be persistent.

Table III. Pharmacokinetic parameters for rebamipide following oral administration of granules or a tablet at a dose of 100mg in 27 healthy adult male volunteers [mean (SD)] ...

Patterns of palliative radiation near the end of life: A single-institution retrospective analysis. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include ...

Please provide your email address to receive an email when new articles are posted on . Rebamipide restores the enterohematic barrier. Patients with post-COVID syndrome had elevated C-reactive protein ...

Prevalence and associated factors of anxiety and depression in patients with metastatic gastrointestinal cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...

About the Rebamipide Ophthalmic Suspension Phase 3 Clinical Study This Phase 3 clinical study will be conducted to determine the efficacy and safety of 2% rebamipide ophthalmic suspension in subjects ...

Please provide your email address to receive an email when new articles are posted on . Rebamipide ophthalmic suspension may be an effective treatment to improve ocular surface parameters and optical ...

Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. today announced that they have entered into a definitive agreement to co-develop Rebamipide ophthalmic suspension (hereinafter, Rebamipide), Otsuka's ...